Venus Remedies Balance Sheet Health
Financial Health criteria checks 6/6
Venus Remedies has a total shareholder equity of ₹4.7B and total debt of ₹417.4M, which brings its debt-to-equity ratio to 8.9%. Its total assets and total liabilities are ₹6.4B and ₹1.7B respectively. Venus Remedies's EBIT is ₹365.1M making its interest coverage ratio -18.5. It has cash and short-term investments of ₹707.5M.
Key information
8.9%
Debt to equity ratio
₹417.40m
Debt
| Interest coverage ratio | -18.5x |
| Cash | ₹707.50m |
| Equity | ₹4.71b |
| Total liabilities | ₹1.69b |
| Total assets | ₹6.40b |
Recent financial health updates
Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly
Jun 03
Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
May 31Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
Feb 01We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt
Jan 14Is Venus Remedies (NSE:VENUSREM) A Risky Investment?
Sep 22Recent updates
Venus Remedies Limited (NSE:VENUSREM) Not Doing Enough For Some Investors As Its Shares Slump 26%
Mar 14Calculating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)
Oct 31Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly
Jun 03Estimating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)
Jul 15Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
May 31I Ran A Stock Scan For Earnings Growth And Venus Remedies (NSE:VENUSREM) Passed With Ease
Mar 30Why Investors Shouldn't Be Surprised By Venus Remedies Limited's (NSE:VENUSREM) 25% Share Price Plunge
Feb 24Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
Feb 01Here's Why We Think Venus Remedies (NSE:VENUSREM) Is Well Worth Watching
Nov 16Venus Remedies Limited's (NSE:VENUSREM) Stock Is Going Strong: Have Financials A Role To Play?
Mar 11We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt
Jan 14Does Venus Remedies's (NSE:VENUSREM) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 23Is Venus Remedies (NSE:VENUSREM) A Risky Investment?
Sep 22Financial Position Analysis
Short Term Liabilities: VENUSREM's short term assets (₹3.7B) exceed its short term liabilities (₹1.1B).
Long Term Liabilities: VENUSREM's short term assets (₹3.7B) exceed its long term liabilities (₹595.1M).
Debt to Equity History and Analysis
Debt Level: VENUSREM has more cash than its total debt.
Reducing Debt: VENUSREM's debt to equity ratio has reduced from 88.3% to 8.9% over the past 5 years.
Debt Coverage: VENUSREM's debt is well covered by operating cash flow (36%).
Interest Coverage: VENUSREM earns more interest than it pays, so coverage of interest payments is not a concern.